In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a GLUCOVANCE Drug Master File in Korea (GLUCOVANCE KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of GLUCOVANCE. The MFDS reviews the GLUCOVANCE KDMF as part of the drug registration process and uses the information provided in the GLUCOVANCE KDMF to evaluate the safety and efficacy of the drug.
After submitting a GLUCOVANCE KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their GLUCOVANCE API can apply through the Korea Drug Master File (KDMF).
click here to find a list of GLUCOVANCE suppliers with KDMF on PharmaCompass.